Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Centre de Regulacio Genomica - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013158
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers facilities such as light microscopy unit, bioinformatics unit, biomolecular screening, protein technologies unit, and others. CRG provides units including genomics unit, histology unit and scientific information technologies. The institute offers courses for undergraduates, PhD students, postdoctoral, researchers and scientists. It also provides technology transfer services. The institute operates through genomics unit, tissue engineering unit and in-house services. CRG is headquartered in Barcelona, Spain.

Centre de Regulacio Genomica – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 9
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 10
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 11
Centre de Regulacio Genomica – Key Competitors 12
Centre de Regulacio Genomica – Key Employees 13
Centre de Regulacio Genomica – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Key Facts 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 9
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 10
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 11
Centre de Regulacio Genomica, Key Competitors 12
Centre de Regulacio Genomica, Key Employees 13

★海外企業調査レポート[Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acorn Energy, Inc. (ACFN)-石油・ガス分野:企業M&A・提携分析
    Summary Acorn Energy, Inc. (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and com …
  • FANUC CORPORATION:企業の戦略・SWOT・財務分析
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Aevi Genomic Medicine Inc (GNMX):企業の財務・戦略的SWOT分析
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • Belk Inc:戦略・SWOT・企業財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • CEZ Group:電力:M&Aディール及び事業提携情報
    Summary CEZ Group (CEZ), a subsidiary of CEZ AS, is an integrated electricity conglomerate company. The company produces and markets electricity. It generates, trades, and distributes power and heat. CEZ also provides coal mining services. The company offers services such as telecommunications, info …
  • Sciessent LLC:企業の戦略的SWOT分析
    Sciessent LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gaia, Inc. (GAIA):企業の財務・戦略的SWOT分析
    Gaia, Inc. (GAIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Refresco Gerber B.V.:企業の戦略・SWOT・財務情報
    Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report Summary Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Quadrise Fuels International Plc (QFI):企業の財務・戦略的SWOT分析
    Quadrise Fuels International Plc (QFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • China Sunshine Paper Holdings Company Limited:戦略・SWOT・企業財務分析
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Fomento de Construcciones y Contratas S.A.:戦略・SWOT・企業財務分析
    Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report Summary Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Taiheiyo Cement Corporation:企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BlackPearl Resources Inc (PXX):石油・ガス:M&Aディール及び事業提携情報
    Summary BlackPearl Resources Inc (BlackPearl), formerly Pearl Exploration and Production Ltd, is an oil and gas company that explores, develops and produces heavy oil and oil sands assets in western Canada. The company's properties include Blackrod property, Onion Lake property and Mooney property i …
  • Valmieras Stikla Skiedra AS:企業の戦略・SWOT・財務情報
    Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report Summary Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • London Stock Exchange Group Plc:戦略・SWOT・企業財務分析
    London Stock Exchange Group Plc - Strategy, SWOT and Corporate Finance Report Summary London Stock Exchange Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • New China Life Insurance Company Ltd.
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Grindeks (GRD1R):製薬・医療:M&Aディール及び事業提携情報
    Summary Grindeks focuses on the research, development, manufacture and marketing of novel pharmaceuticals, generic products and active pharmaceutical ingredients (APIs). Its products are indicated for treating diseases in cardiovascular, central nervous system (CNS) and cancer therapeutic categories …
  • Medytox Inc (086900):企業の財務・戦略的SWOT分析
    Summary Medytox Inc (Medytox) develops, manufactures and markets biopharmaceutical products. Its products include botulinum toxin type A product, hyaluronic acid filler, medical devices, prescription cream, toxin detection kits and antitoxin therapeutics for treating skin disorders. The company is a …
  • Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Recepta Biopharma SA (Recepta) is a biotechnology company that offers research and development of drugs used in the treatment of cancer. The company offers antibodies and peptide products. It offers antibodies such as monoclonal antibody hu3s193 - anti-ley, monoclonal antibody 58-1066 - anti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆